Citius Oncology (CTOR) Non-Current Debt (2025 - 2026)

Citius Oncology (CTOR) has reported Non-Current Debt for 2 consecutive years, with $3.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non-Current Debt changed N/A year-over-year to $3.8 million in Q2 2026; TTM through Jun 2026 was $3.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $3.8 million, changed N/A from the prior year.
• Non-Current Debt was $3.8 million for Q2 2026 at Citius Oncology, roughly flat from $3.8 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $3.8 million in Q3 2025 and troughed at $3.8 million in Q3 2025.